Hepatocyte growth factor levels in Legionella pneumonia: A retrospective study

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Higa, Futoshi ^a   Akamine, Morikazu ^a   Furugen, Makoto ^a   Hibiya, Kenji ^a   Koide, Michio ^a   Tamayose, Maki ^a   Tamaki, Yuichiro ^a   Haranaga, Syusaku ^a   Arakaki, Noriko ^a   Yara, Satomi ^a   Tateyama, Masao ^a   Fujita, Jiro ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; LACTATE DEHYDROGENASE; SCATTER FACTOR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEGIONNAIRE DISEASE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETROSPECTIVE STUDY; AGED; BACTERIAL PNEUMONIA; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 79953122329     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-74     Document Type: Article

References (15)

1. Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002, 282(5):L924-940.
2. Morimoto K, Amano H, Sonoda F, Baba M, Senba M, Yoshimine H, Yamamoto H, Ii T, Oishi K, Nagatake T. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol 2001, 24(5):608-615.
3. Jaffre S, Dehoux M, Paugam C, Grenier A, Chollet-Martin S, Stern JB, Mantz J, Aubier M, Crestani B. Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am J Physiol Lung Cell Mol Physiol 2002, 282(2):L310-315.
4. Hojo SFJ, Yamadori I, Kishimoto T, Miyazaki H, Obayashi Y, Yamaji Y, Takahara J. Serial measurements of plasma hepatocyte growth factor in patients with pneumonia following cancer chemotherapy. J Infect Chemother 1996, 2:49-51.
5. Nayeri F, Millinger E, Nilsson I, Zetterstrom, Brudin L, Forsberg P. Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med 2002, 96(2):115-119. 10.1053/rmed.2001.1225, 11860168.
6. Abednazari H, Xu J, Millinger E, Brudin L, Forsberg P, Nayeri F. Hepatocyte growth factor is a better indicator of therapeutic response than C-reactive protein within the first day of treatment in pneumonia. Chemotherapy 2006, 52(5):260-263. 10.1159/000094868, 16899975.
7. Verghese GM, McCormick-Shannon K, Mason RJ, Matthay MA. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med 1998, 158(2):386-394.
8. Demello D, Kierol-Andrews L, Scalise PJ. Severe sepsis and acute respiratory distress syndrome from community-acquired legionella pneumonia: case report. Am J Crit Care 2007, 16(3):320-317.
9. Nayeri F, Brudin L, Darelid J, Nilsson I, Fryden A, Soderstrom C, Forsberg P. Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia. Scand J Infect Dis 2002, 34(7):500-504. 10.1080/00365540110080890, 12195875.
10. Dominguez A, Alvarez J, Sabria M, Carmona G, Torner N, Oviedo M, Cayla J, Minguell S, Barrabeig I, Sala M, et al. Factors influencing the case-fatality rate of Legionnaires' disease. Int J Tuberc Lung Dis 2009, 13(3):407-412.
11. von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Luck C. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 2008, 46(9):1356-1364. 10.1086/586741, 18419436.
12. Jespersen S, Sogaard OS, Schonheyder HC, Fine MJ, Ostergaard L. Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: a Danish historical cohort study. BMC Infect Dis 2010, 10:124. 10.1186/1471-2334-10-124, 2881091, 20492639.
13. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336(4):243-250. 10.1056/NEJM199701233360402, 8995086.
14. Nayeri F, Nilsson I, Skude G, Brudin L, Soderstrom C. Hepatocyte growth factor (HGF) in patients with pneumonia: a comparison between survivors and non-survivors. Scand J Infect Dis 1998, 30(4):405-409. 10.1080/00365549850160729, 9817523.
15. Maeda J, Ueki N, Hada T, Higashino K. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am J Respir Crit Care Med 1995, 152(5 Pt 1):1587-1591.